Bladder, Breast, Colorectal Cancer, and Melanoma- Treatment Summary Table

Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.

Legend:
green line green - headed in the right direction
red line red - headed in the wrong direction
black line black - stable or non-significant change (NSC)
purple purple - indeterminate
blue blue - Healthy People 2030 target
Measure Name Bladder Cancer Treatment Breast Cancer Treatment Colorectal Cancer Treatment Melanoma of the Skin Treatment
Year Range 1995-2019 1987-2015 1987-2015 2001-2018
Measure

Percentage of individuals receiving intravesical therapy.

Percentage of individuals receiving systemic therapy.

Percentage of women aged 20 and older, diagnosed with early stage breast cancer (stage I or II), receiving breast-conserving surgery and radiation treatment.

Percentage of women aged 20 and older, diagnosed with node-positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy.

Note: This measure includes women with both hormone receptor positive and negative breast cancer.

Percent of individuals, aged 20 years and older, diagnosed with stage III colon cancer who received adjuvant chemotherapy or diagnosed with stage II or stage III rectal cancer who received  chemotherapy with or without radiation therapy.

Percentage of individuals with advanced (stage III or IV) melanoma of the skin receiving chemotherapy.
Recent Summary Trend Non-Significant Change Stable Rising Rising
Recent Summary Trend Year Range 2009-2019 2010-2015 2010-2015 2011-2018
Desired Direction Rising Rising Rising Rising
Summary Graph Summary graph for Bladder Cancer Treatment, Click to see detailed view of graph Summary graph for Breast Cancer Treatment, Click to see detailed view of graph Summary graph for Colorectal Cancer Treatment, Click to see detailed view of graph Summary graph for Melanoma of the Skin Treatment, Click to see detailed view of graph
Trends and Most Recent Estimates In 2019, 35.5% of patients with non-muscle invasive disease received intravesical therapy. In 2015, 64.2% of women diagnosed with node positive breast cancer, received multi-agent chemotherapy. In 2015, 70.3% of stage III colon and stage II and III rectal patients received adjuvant chemotherapy. In 2018, 79.4% of stage III or IV melanoma of the skin patients aged 20 years and older received chemotherapy.
Healthy People 2030 Target No Healthy People Target for this measure. No Healthy People Target for this measure. No Healthy People Target for this measure. No Healthy People Target for this measure.
More Information Bladder Cancer Treatment Breast Cancer Treatment Colorectal Cancer Treatment Melanoma of the Skin Treatment
Last Updated August 2023 August 2023 August 2023 August 2023
Measure Name: Melanoma of the Skin Treatment
Measure Name Melanoma of the Skin Treatment
Year Range 2001-2018
Measure

Percentage of individuals with advanced (stage III or IV) melanoma of the skin receiving chemotherapy.
Recent Summary Trend Rising
Recent Summary Trend Year Range 2011-2018
Desired Direction Rising
Summary Graph Summary graph for Melanoma of the Skin Treatment, Click to see detailed view of graph
Trends and Most Recent Estimates In 2018, 79.4% of stage III or IV melanoma of the skin patients aged 20 years and older received chemotherapy.
Healthy People 2020 Target No Healthy People Target for this measure.
More Information Melanoma of the Skin Treatment
Measure Name: Breast Cancer Treatment
Measure Name Breast Cancer Treatment
Year Range 1987-2015
Measure

Percentage of women aged 20 and older, diagnosed with early stage breast cancer (stage I or II), receiving breast-conserving surgery and radiation treatment.

Percentage of women aged 20 and older, diagnosed with node-positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy.

Note: This measure includes women with both hormone receptor positive and negative breast cancer.
Recent Summary Trend Stable
Recent Summary Trend Year Range 2010-2015
Desired Direction Rising
Summary Graph Summary graph for Breast Cancer Treatment, Click to see detailed view of graph
Trends and Most Recent Estimates In 2015, 64.2% of women diagnosed with node positive breast cancer, received multi-agent chemotherapy.
Healthy People 2020 Target No Healthy People Target for this measure.
More Information Breast Cancer Treatment
Measure Name: Bladder Cancer Treatment
Measure Name Bladder Cancer Treatment
Year Range 1995-2019
Measure

Percentage of individuals receiving intravesical therapy.

Percentage of individuals receiving systemic therapy.
Recent Summary Trend Non-Significant Change
Recent Summary Trend Year Range 2009-2019
Desired Direction Rising
Summary Graph Summary graph for Bladder Cancer Treatment, Click to see detailed view of graph
Trends and Most Recent Estimates In 2019, 35.5% of patients with non-muscle invasive disease received intravesical therapy.
Healthy People 2020 Target No Healthy People Target for this measure.
More Information Bladder Cancer Treatment
Measure Name: Colorectal Cancer Treatment
Measure Name Colorectal Cancer Treatment
Year Range 1987-2015
Measure

Percent of individuals, aged 20 years and older, diagnosed with stage III colon cancer who received adjuvant chemotherapy or diagnosed with stage II or stage III rectal cancer who received  chemotherapy with or without radiation therapy.
Recent Summary Trend Rising
Recent Summary Trend Year Range 2010-2015
Desired Direction Rising
Summary Graph Summary graph for Colorectal Cancer Treatment, Click to see detailed view of graph
Trends and Most Recent Estimates In 2015, 70.3% of stage III colon and stage II and III rectal patients received adjuvant chemotherapy.
Healthy People 2020 Target No Healthy People Target for this measure.
More Information Colorectal Cancer Treatment